dopamine: be contraindicated in pheochromocytoma

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents neurotransmitter
Weight: 0.73
, chemical
Weight: 0.69
, hormone
Weight: 0.68
, neuron
Weight: 0.67
, drug
Weight: 0.67
Siblings acetylcholine
Weight: 0.41
, serotonin
Weight: 0.41
, vasopressin
Weight: 0.39
, oxytocin
Weight: 0.39
, norepinephrine
Weight: 0.38

Related properties

Property Similarity
be contraindicated in pheochromocytoma 1.00
be contraindicated in hypovolemic shock 0.92
be contraindicated in shock 0.91
be used for bradycardia 0.79
be used in neonates 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.56
Plausible(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.63
¬ Salient(dopamine, be contraindicated in pheochromocytoma)

Similarity expansion

0.61
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.91
Evidence: 0.59
Typical(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.52
¬ Typical(dopamine, be contraindicated in shock)
0.61
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.77
Evidence: 0.59
Typical(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.19
¬ Typical(dopamine, be used in neonates)
0.61
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.92
Evidence: 0.59
Typical(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.55
¬ Typical(dopamine, be contraindicated in hypovolemic shock)
0.61
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.79
Evidence: 0.63
Salient(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.26
¬ Salient(dopamine, be used for bradycardia)
0.60
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.79
Evidence: 0.56
Plausible(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.26
¬ Plausible(dopamine, be used for bradycardia)
0.58
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.79
Evidence: 0.61
Remarkable(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.35
¬ Remarkable(dopamine, be used for bradycardia)
0.58
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.91
Evidence: 0.56
Plausible(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.58
¬ Plausible(dopamine, be contraindicated in shock)
0.58
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.92
Evidence: 0.56
Plausible(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.60
¬ Plausible(dopamine, be contraindicated in hypovolemic shock)
0.57
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.79
Evidence: 0.59
Typical(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.36
¬ Typical(dopamine, be used for bradycardia)
0.57
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.77
Evidence: 0.56
Plausible(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.31
¬ Plausible(dopamine, be used in neonates)
0.56
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.92
Evidence: 0.63
Salient(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.75
¬ Salient(dopamine, be contraindicated in hypovolemic shock)
0.56
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.91
Evidence: 0.63
Salient(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.73
¬ Salient(dopamine, be contraindicated in shock)
0.56
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.77
Evidence: 0.63
Salient(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.41
¬ Salient(dopamine, be used in neonates)
0.54
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.92
Evidence: 0.61
Remarkable(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.78
¬ Remarkable(dopamine, be contraindicated in hypovolemic shock)
0.53
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.91
Evidence: 0.61
Remarkable(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.79
¬ Remarkable(dopamine, be contraindicated in shock)
0.46
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.77
Evidence: 0.61
Remarkable(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.78
¬ Remarkable(dopamine, be used in neonates)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.63
Salient(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.59
¬ Typical(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.61
¬ Remarkable(dopamine, be contraindicated in pheochromocytoma)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.56
Plausible(dopamine, be contraindicated in pheochromocytoma) ⋁
Evidence: 0.59
¬ Typical(dopamine, be contraindicated in pheochromocytoma)